A Phase I Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors

BR101 injection was administered once for 28 days observation period and then weekly until the subject experienced unacceptable toxicity, disease progression, poor compliance, pregnancy, informed withdrawal, death, study interruption, and withdrawal from the study